Floatz logo

10 assets in Primary Systemic Amyloidosis

Therapeutic assets addressing Primary Systemic Amyloidosis, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Evuzamitide
Primary Systemic Amyloidosis
University of Tennessee Graduate School of MedicineP1/2B (57)
99MTC-P5
Primary Systemic Amyloidosis
University of Tennessee Graduate School of MedicineP1CC (43)
99mtc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.
Primary Systemic Amyloidosis
University of Tennessee Graduate School of MedicineP1CC (43)
Technetium, Ion (99M Tc4+)
Primary Systemic Amyloidosis
University of Tennessee Graduate School of MedicineP1CC (43)
Technetium Tc 99M Pyrophosphate
Primary Systemic Amyloidosis
University of Tennessee Graduate School of MedicineP1CC (43)
Florbetaben
Primary Systemic Amyloidosis
University of ZurichN/AD (30)
124I-AT03
Primary Systemic Amyloidosis
Attralus, Inc.P1NR ()